LIFEVANTAGE CORP Commissions Payable to Broker-Dealers and Clearing Organizations
LIFEVANTAGE CORP (LFVN) had Commissions Payable to Broker-Dealers and Clearing Organizations of $7.20 million as of 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:CommissionsPayableToBrokerDealersAndClearingOrganizations · last filed 2013-05-09
- 2013-03-31: Commissions Payable to Broker-Dealers and Clearing Organizations $7.20M.
- 2012-12-31: Commissions Payable to Broker-Dealers and Clearing Organizations $6.24M.
- 2012-09-30: Commissions Payable to Broker-Dealers and Clearing Organizations $6.52M.
- 2012-06-30: Commissions Payable to Broker-Dealers and Clearing Organizations $5.63M; Commissions Payable to Broker-Dealers and Clearing Organizations as first filed $5.63M.
| Period end | Commissions Payable to Broker-Dealers and Clearing Organizations | Commissions Payable to Broker-Dealers and Clearing Organizations as first filed |
|---|---|---|
| 2013-03-31 | $7.20M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $6.24M 10-Q · filed 2013-02-07 | |
| 2012-09-30 | $6.52M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $5.63M 10-Q · filed 2013-05-09 | $5.63M 10-K · filed 2012-09-10 |
| 2012-03-31 | $4.43M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $3.03M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $2.40M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $2.00M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |